tradingkey.logo

Alcon AG

ALC
79.190USD
+0.390+0.49%
收盤 12/15, 16:00美東報價延遲15分鐘
39.17B總市值
37.40本益比TTM

Alcon AG

79.190
+0.390+0.49%

關於 Alcon AG 公司

Alcon AG is a Switzerland-based eye care company. The Company research, develop, manufacture, distribute and sell a full suite of eye care products within two key businesses: Surgical and Vision Care. The Company’s Surgical business is focused on ophthalmic products for cataract surgery, vitreoretinal surgery, refractive laser surgery and glaucoma surgery. The surgical portfolio includes implantables, consumables and surgical equipment required for these procedures and supports the end-to-end needs of the ophthalmic surgeon. The Company’s Vision Care business comprises of daily disposable, reusable and color-enhancing contact lenses and a portfolio of ocular health products, including products for dry eye, ocular allergies, glaucoma, and contact lens care, as well as ocular vitamins and redness relievers. The Company operates in 60 countries and serves consumers and patients in over 140 countries.

Alcon AG簡介

公司代碼ALC
公司名稱Alcon AG
上市日期Apr 09, 2019
CEOEndicott (David J)
員工數量25599
證券類型Ordinary Share
年結日Apr 09
公司地址Rue Louis d'Affry 6
城市FRIBOURG
上市交易所NASDAQ OMX NASDAQ Basic NYSE
國家Switzerland
郵編1700
電話41589113800
網址https://www.alcon.ch/
公司代碼ALC
上市日期Apr 09, 2019
CEOEndicott (David J)

Alcon AG公司高管

名稱
名稱/職務
職務
持股
持股變動
Mr. David J. Endicott
Mr. David J. Endicott
Chief Executive Officer, Director
Chief Executive Officer, Director
207.11K
-11.08%
Mr. Timothy C. (Tim) Stonesifer
Mr. Timothy C. (Tim) Stonesifer
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
134.23K
+38.34%
Mr. Rajkumar Narayanan
Mr. Rajkumar Narayanan
Senior Vice President, President - International
Senior Vice President, President - International
37.83K
+9.30%
Mr. Ian Bell
Mr. Ian Bell
Chief Operating Officer, Senior Vice President
Chief Operating Officer, Senior Vice President
30.23K
-24.88%
Ms. Karen J. May, CPA
Ms. Karen J. May, CPA
Independent Director
Independent Director
28.32K
+11.14%
Mr. Laurent Attias
Mr. Laurent Attias
Senior Vice President - Corporate Strategy, Business Development and Licensing (BD&L) and Mergers and Acquisitions (M&A)
Senior Vice President - Corporate Strategy, Business Development and Licensing (BD&L) and Mergers and Acquisitions (M&A)
22.62K
+15.19%
Mr. Scott Harlan Maw
Mr. Scott Harlan Maw
Independent Director
Independent Director
17.26K
+14.57%
Ms. Ines Poeschel
Ms. Ines Poeschel
Independent Director
Independent Director
12.08K
+15.09%
Ms. Lynn Dorsey Bleil
Ms. Lynn Dorsey Bleil
Independent Director
Independent Director
10.94K
+13.26%
Ms. Deborah Di Sanzo
Ms. Deborah Di Sanzo
Director
Director
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. David J. Endicott
Mr. David J. Endicott
Chief Executive Officer, Director
Chief Executive Officer, Director
207.11K
-11.08%
Mr. Timothy C. (Tim) Stonesifer
Mr. Timothy C. (Tim) Stonesifer
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
134.23K
+38.34%
Mr. Rajkumar Narayanan
Mr. Rajkumar Narayanan
Senior Vice President, President - International
Senior Vice President, President - International
37.83K
+9.30%
Mr. Ian Bell
Mr. Ian Bell
Chief Operating Officer, Senior Vice President
Chief Operating Officer, Senior Vice President
30.23K
-24.88%
Ms. Karen J. May, CPA
Ms. Karen J. May, CPA
Independent Director
Independent Director
28.32K
+11.14%
Mr. Laurent Attias
Mr. Laurent Attias
Senior Vice President - Corporate Strategy, Business Development and Licensing (BD&L) and Mergers and Acquisitions (M&A)
Senior Vice President - Corporate Strategy, Business Development and Licensing (BD&L) and Mergers and Acquisitions (M&A)
22.62K
+15.19%

收入明細

單位: USD更新時間: 10月6日 週一
單位: USD更新時間: 10月6日 週一
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
業務USD
名稱
營收
佔比
Consumables
777.00M
30.15%
Contact lenses
692.00M
26.85%
Implantables
456.00M
17.69%
Ocular health
430.00M
16.69%
Equipment/other
222.00M
8.61%
Sales to Novartis Group
19.00M
0.74%
地區USD
名稱
營收
佔比
International
1.42B
54.99%
United States
1.16B
45.01%
業務
地區
業務USD
名稱
營收
佔比
Consumables
777.00M
30.15%
Contact lenses
692.00M
26.85%
Implantables
456.00M
17.69%
Ocular health
430.00M
16.69%
Equipment/other
222.00M
8.61%
Sales to Novartis Group
19.00M
0.74%

股東統計

更新時間: 11月27日 週四
更新時間: 11月27日 週四
持股股東
股東類型
持股股東
持股股東
佔比
BlackRock Advisors (UK) Limited
4.94%
The Vanguard Group, Inc.
4.20%
UBS Fund Management (Switzerland) AG
2.29%
Norges Bank Investment Management (NBIM)
2.27%
Aristotle Capital Management, LLC
2.14%
其他
84.16%
持股股東
持股股東
佔比
BlackRock Advisors (UK) Limited
4.94%
The Vanguard Group, Inc.
4.20%
UBS Fund Management (Switzerland) AG
2.29%
Norges Bank Investment Management (NBIM)
2.27%
Aristotle Capital Management, LLC
2.14%
其他
84.16%
股東類型
持股股東
佔比
Investment Advisor
31.53%
Investment Advisor/Hedge Fund
24.78%
Bank and Trust
4.10%
Sovereign Wealth Fund
2.35%
Hedge Fund
2.09%
Research Firm
1.93%
Pension Fund
1.41%
Individual Investor
0.13%
Insurance Company
0.07%
其他
31.62%

機構持股

更新時間: 12月8日 週一
更新時間: 12月8日 週一
報告期間
機構數
持股數
持股佔比
持股變動
2025Q4
1623
342.44M
72.26%
+507.76K
2025Q3
1664
342.40M
72.42%
-9.24M
2025Q2
1658
350.50M
70.82%
+3.47M
2025Q1
1649
340.47M
77.49%
-46.78M
2024Q4
1637
370.92M
68.31%
+36.10M
2024Q3
1614
334.31M
67.55%
+3.20M
2024Q2
1581
336.83M
74.41%
-28.77M
2024Q1
1567
336.16M
66.45%
+4.09M
2023Q4
1583
325.43M
67.42%
+1.37M
2023Q3
1565
323.23M
69.34%
-9.13M
查看更多

股東持股明細

名稱
持股數
佔比
持股變動
變動比例
公告日期
BlackRock Advisors (UK) Limited
24.68M
4.94%
--
--
Dec 31, 2024
The Vanguard Group, Inc.
20.64M
4.13%
+781.14K
+3.93%
Jun 30, 2025
UBS Fund Management (Switzerland) AG
11.47M
2.29%
-68.71K
-0.60%
Jun 30, 2025
Norges Bank Investment Management (NBIM)
11.35M
2.27%
-1.28M
-10.12%
Jun 30, 2025
Aristotle Capital Management, LLC
12.04M
2.41%
-191.15K
-1.56%
Jun 30, 2025
T. Rowe Price Associates, Inc.
6.98M
1.4%
+2.06M
+41.82%
Jun 30, 2025
Zürcher Kantonalbank (Asset Management)
9.14M
1.83%
+628.34K
+7.38%
Jun 30, 2025
AKO Capital LLP
7.71M
1.54%
+597.84K
+8.40%
Jun 30, 2025
Fidelity Management & Research Company LLC
10.21M
2.04%
-4.82M
-32.06%
Jun 30, 2025
Select Equity Group, L.P.
6.76M
1.35%
+1.28M
+23.44%
Jun 30, 2025
查看更多

持股ETF

更新時間: 12月6日 週六
更新時間: 12月6日 週六
機構名稱
佔比
Global X Aging Population ETF
2.36%
Franklin FTSE Switzerland ETF
2.28%
iShares MSCI Switzerland ETF
2.2%
First Trust Indxx Medical Devices ETF
2.06%
Running Oak Efficient Growth ETF
1.77%
Global X S&P Catholic Values Developed ex-US ETF
1.07%
JPMorgan BetaBuilders Europe ETF
0.59%
iShares Global Healthcare ETF
0.53%
ALPS O'Shares International Developed Quality Dividend ETF
0.45%
Wahed Dow Jones Islamic World ETF
0.44%
查看更多
Global X Aging Population ETF
佔比2.36%
Franklin FTSE Switzerland ETF
佔比2.28%
iShares MSCI Switzerland ETF
佔比2.2%
First Trust Indxx Medical Devices ETF
佔比2.06%
Running Oak Efficient Growth ETF
佔比1.77%
Global X S&P Catholic Values Developed ex-US ETF
佔比1.07%
JPMorgan BetaBuilders Europe ETF
佔比0.59%
iShares Global Healthcare ETF
佔比0.53%
ALPS O'Shares International Developed Quality Dividend ETF
佔比0.45%
Wahed Dow Jones Islamic World ETF
佔比0.44%

分紅派息

近5年累計派現 400.00M 美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
Mar 01, 2022
ALC.NB Final Cash Dividend of gross CHF 0.2 paid on May 05, 2022 going ex on Apr 29, 2022
May 04, 2022
May 05, 2022
May 03, 2022
Feb 24, 2021
ALC.NB Final Cash Dividend of gross CHF 0.1 paid on May 06, 2021 going ex on May 04, 2021
May 05, 2021
May 06, 2021
May 04, 2021

拆合股

公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據

常見問題

Alcon AG的前五大股東是誰?

Alcon AG的前五大股東如下:
BlackRock Advisors (UK) Limited
持有股份:24.68M
佔總股份比例:4.94%。
The Vanguard Group, Inc.
持有股份:20.64M
佔總股份比例:4.13%。
UBS Fund Management (Switzerland) AG
持有股份:11.47M
佔總股份比例:2.29%。
Norges Bank Investment Management (NBIM)
持有股份:11.35M
佔總股份比例:2.27%。
Aristotle Capital Management, LLC
持有股份:12.04M
佔總股份比例:2.41%。

Alcon AG的前三大股東類型是什麼?

Alcon AG 的前三大股東類型分別是:
BlackRock Advisors (UK) Limited
The Vanguard Group, Inc.
UBS Fund Management (Switzerland) AG

有多少機構持有Alcon AG(ALC)的股份?

截至2025Q4,共有1623家機構持有Alcon AG的股份,合計持有的股份價值約為342.44M,占公司總股份的72.26% 。與2025Q3相比,機構持股有所增加,增幅為-0.16%。

哪個業務部門對Alcon AG的收入貢獻最大?

在FY2025Q2,Consumables業務部門對Alcon AG的收入貢獻最大,創收777.00M,占總收入的30.15% 。
KeyAI